Innovation
11 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 140 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 8 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Biotechnology company focused on pioneering the development of microbiome modulators, bioactive therapies
11 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 140 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 8 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |